A new observational study finds patients in the hospital for COVID-19 have high levels of soluble urokinase receptor (suPAR), an immune-derived pathogenic protein that is strongly predictive of kidney injury.Read more
Obesity is contributing to worse outcomes in people with COVID-19. Dr. Naomi Parrella, medical director of the Rush Center for Weight Loss and Bariatric Surgery, explains how managing your weight can lower your risk for severe COVID symptoms and help you prevent other chronic diseases.Read more
The American Educational Research Association (AERA) and the Organisation for Economic Co-operation and Development (OECD) will co-host a webinar on “Education Research Worldwide in a Covid and Post-Covid World” at 9:30-11:00 am EDT Wednesday, September 23.Read more
Why do some people have severe reactions to COVID whereas others do not? Are there overlooked or unexplained factors in how people respond to the COVID virus connected to their gut microbiome? Could microbiome predict the severity of illness among those exposed to the virus?
The American College of Rheumatology (ACR) will hold its first virtual Advocates for Arthritis event on Tuesday, Sept. 15, where more than 120 rheumatologists, rheumatology health professionals, and patient advocates will meet with lawmakers via video to discuss the healthcare challenges they are facing in the midst of COVID-19.Read more
The effectiveness of educational content aimed at correcting misconceptions about the risks, transmission, and prevention of Covid-19 is largely influenced by a person’s prevailing moral values, according to a new study published today in Educational Researcher, a peer-reviewed journal of the American Educational Research Association.Read more
Front-line Worker Story: Ebony Hunter — Teamwork Will Get Us Through
It seems there will never be enough “thank-you’s” for the incredible doctors, nurses, technicians and support staff members who are working around the clock to help patients who have COVID-19, the dangerous coronavirus disease. Their dedication, determination and spirit enable Johns Hopkins to deliver the promise of medicine.
As the COVID-19 pandemic continues to impact the world in sometimes devastating and unexpected ways, a more well-known illness — the flu — will make its annual debut in the coming weeks. Flu activity tends to increase in October and can run as late as May. It’s too soon to tell how flu season will definitively affect the current pandemic. However, Johns Hopkins Medicine experts say prevention will be key in reducing the spread of both illnesses, including getting an annual flu vaccine, washing hands, wearing a face mask or covering, and maintaining proper physical distancing.Read more
Rush University Medical Center is recruiting participants for a nationwide trial of a COVID-19 vaccine developed by the University of Oxford in England and AstraZeneca, a multinational pharmaceutical company.Read more
This fall presents a challenge for parents as their kids adjust to a school year unlike any other. Matthew McConn,Read more
Thomas Jefferson University Awarded $508,000 by the Commonwealth to support CoraVax™, a patented COVID-19 vaccineRead more
It has been hypothesized that SARS-CoV2 spread among people via droplets that come from the nose and mouth or through contact with contaminated objects and surfaces. Researchers at Rutgers Cancer Institute found that environmental surface testing at the center’s Radiation Oncology Department located within Robert Wood Johnson University Hospital, an RWJBarnabas Health facility, during the height of the COVID-19 pandemic in the state showed no detectable SARS-CoV2 – the virus that causes COVID-19.Read more